Colon cancer: curcumin is an activator of PTPN1 and can reduce cell motility in colon cancer via dephosphorylation of pTyr(421)-CTTN, which could be exploited for novel therapeutic approaches in colon cancer. Here, PTPN1 is linked to malignant colon neoplasm.